Caveolin-1 differentially regulates the transforming growth factor-β and epidermal growth factor signaling pathways

Shih-Chuan Hsiao1, Wei-Hsiang Liao2, Heng-Ai Chang3

  • 1Department of Hematology & Oncology, Saint Martin de Porres Hospital, Chiayi 600, Taiwan.

Insights

Caveolin-1 differentially regulates TGF-β receptor (TGFβR) and EGF receptor (EGFR) signaling pathways. Targeting caveolin-1 may offer a therapeutic strategy for fibrosis and cancer.

Area of Science:

  • Cell biology
  • Molecular signaling
  • Cancer research

Background:

  • Caveolin-1 interacts with TGF-β receptor (TGFβR) and EGF receptor (EGFR) signaling.
  • This interaction is implicated in advanced cancers and tissue fibrosis.
  • The precise mechanism of caveolin-1's role in TGFβR and EGFR signaling remains unclear.

Purpose of the Study:

  • To investigate caveolin-1's involvement in canonical and non-canonical TGFβR and EGFR signaling transactivation.
  • To elucidate the specific mechanisms by which caveolin-1 modulates these signaling pathways.

Main Methods:

  • Disruption of cholesterol-rich membrane domains using Methyl-β-cyclodextrin (MβCD).
  • Mimicking the caveolin-1 scaffolding domain (CSD) using a CSD peptide.
  • Transfection of Madin-Darby canine kidney cells with wild-type or phosphorylation-defective caveolin-1.

Main Results:

  • Tyrosine 14 of caveolin-1 is crucial for the negative regulation of canonical TGFβR and EGFR signaling.
  • Caveolin-1 inhibited TGF-β1-induced ERK2 activation independently of tyrosine 14 phosphorylation.
  • Caveolin-1 indirectly regulated EGF's non-canonical pathway, as evidenced by Smad3 phosphorylation changes.

Conclusions:

  • Caveolin-1 exhibits differential modulation of TGFβR and EGFR signaling pathways.
  • Targeting caveolin-1 presents a potential therapeutic strategy for diseases involving TGF-β1 and EGF signaling, such as cancer and fibrosis.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K